Tirzepatide is a medication that activates both GIP and GLP-1 receptors to enhance insulin secretion, reduce appetite, and slow gastric emptying, leading to significant weight loss and improved blood sugar control
*Safety info: GLP-1 drugs may have serious side effects, including possible thyroid tumors
Simeglutide tablets and injections have the same composition and pharmacological effects, but differences in administration routes and absorption rates may lead to certain differences in efficacy
May improve hydration, gradual collagen stimulation, smoother texture, and skin tone
Adopt a versatile option
In the muscle atrophy model induced by a high-fat diet (HFD), the two GLP-1RAs liraglutide and semaglutide, effectively improved the state of muscle atrophy by regulating the balance of muscle protein metabolism